Investment Team
-
Current Companies
-
-
Prior Companies
-
P. Sherrill Neff
-
Founding Partner of Quaker BioVentures
-
Previously: President, COO, and Director of Neose Technologies, a publicly traded life sciences company. Senior VP, Corporate Development at U.S. Healthcare, a leading publicly traded HMO. Managing Director in the investment banking division of Alex. Brown & Son. Corporate attorney at Morgan, Lewis & Bockius.
-
Board Responsibilities: Amicus Therapeutics, Biolex Therapeutics, Neuronetics, Optherion, and Regado Biosciences
-
Board Observer Responsibilities: Cempra Pharmaceuticals
-
Prior Board Participation: BioRexis (acquired by Pfizer) and Medmark (acquired by Walgreen Co.)
-
Other: Former Chairman of the Greater Philadelphia Venture Group. Former President of the Pennsylvania Biotechnology Association. Currently board member of National Venture Capital Association (NVCA), Resource Capital Corporation (NYSE:RSO), Biotechnology Institute, the Policy Board of WXPN and Vesper Boat Club. Former board member of the following publicly traded companies: Resource America, The Bancorp, Jefferson Bank and Neose Technologies.
-
Education: B.A. from Wesleyan University and J.D. magna cum laude from the University of Michigan Law School
